Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $3.0 million.

  • Pyxis Oncology's Depreciation & Amortization (CF) fell 27.91% to $527,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is 54.75% up from last year.
  • According to the latest figures from FY2024, Pyxis Oncology's Depreciation & Amortization (CF) is $3.0 million, which was up 54.75% from $1.9 million recorded in FY2023.
  • Pyxis Oncology's Depreciation & Amortization (CF)'s 5-year high stood at $3.0 million during FY2024, with a 5-year trough of $500,000 in FY2020.
  • In the last 3 years, Pyxis Oncology's Depreciation & Amortization (CF) had a median value of $1.9 million in 2023 and averaged $1.9 million.
  • Data for Pyxis Oncology's Depreciation & Amortization (CF) shows a peak YoY soared of 171.79% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Pyxis Oncology's Depreciation & Amortization (CF) stood at $500,000 in 2020, then increased by 29.40% to $647,000 in 2021, then rose by 9.58% to $709,000 in 2022, then soared by 171.79% to $1.9 million in 2023, then soared by 54.75% to $3.0 million in 2024.